North America Biobanking Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The North America Biobanking Market Report is segmented by Equipment, Media, Services, Application (Regenerative Medicine, Drug Discovery, Disease Research), and Geography.

North America Biobanking Market Size

View Global Report
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 8.50 %

Major Players

North America Biobanks Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Biobanks Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Biobanking Market Analysis

Stem cell practices are on the rise and are contributing to the development of new solutions for various diseases. Several advancements have been made in regenerative medicine through stem cell technology over the past decade. Thus, it has become one of the vital treatment methods for diseases, such as Alzheimer's, diabetes, cancer, and rare genetic diseases. In order to benefit from the existing therapies, umbilical cord cells and other stem cells are preserved in Biobanks. According to the Hastings Center, a non-profit organization, 300 million bio-specimen have been stored in the United States in various public and private biobanks. With the increase in awareness about stem cell therapies, there have been a larger number of parents, who choose umbilical cord banks for their children. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. However, other factors such as rising burden of chronic diseases and increasing healthcare expenditure are also expected to drive the market in the forecast period

North America Biobanking Market Trends

This section covers the major market trends shaping the North America Biobanks Market according to our research experts:

Alarm Monitoring Systems Segment is Expected to Show Better Growth in the Forecast Years

Based on Equipment, the market is segmented into cryogenic storage system, alarm monitoring systems and other equipment. Stem cell banking is considered as one of the most promising and emerging fields. The cryogenic storage systems, freezers, refrigerators, and all other storage devices in a biobank require continuous monitoring of various processes. This is effectively done only with an alarm monitoring system. Alarms are used at various stages, from filling to continuous monitoring of temperature. Hence, with advancements in technology and the rising adoption of automated storage systems, there is high demand for automated alarm monitoring devices, which is expected to fuel the market growth.

North America Biobanks Market 1

North America Biobanking Industry Overview

The market is competitive and with the entrance of key players, the market is expected to grow due to increased competition among the existing players. For instance, Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, BioLifeSolutions Inc., Chart Industries Inc., Hamilton Company, Qiagen N.V, Sigma-Aldrich Inc. (Merck KGaA), Stemcell Technologies Inc., Thermo Fisher Scientific and VWR International LLC are some of the companies that are operating in  the biobank business on an international level with considerable presence in North America region.

North America Biobanking Market Leaders

  1. BioLifeSolutions Inc.

  2. Hamilton Company

  3. Sigma-Aldrich Inc. (Merck KGaA)

  4. Thermo Fisher Scientific Inc.

  5. VWR International LLC

*Disclaimer: Major Players sorted in no particular order

North America Biobanks Market 2.png
Need More Details on Market Players and Competitors?
Download PDF

North America Biobanking Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases
    • 4.2.2 Advancements in Stem Cell and Regenerative Medicine Research
    • 4.2.3 Increasing Healthcare Expenditure
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Equipment
    • 5.1.1 Cryogenic Storage Systems
    • 5.1.1.1 Refrigerators
    • 5.1.1.2 Ice Machines
    • 5.1.1.3 Freezers
    • 5.1.2 Alarm Monitoring Systems
    • 5.1.3 Other Equipment
  • 5.2 Media
    • 5.2.1 Optimized Media
    • 5.2.2 Non-optimized Media
  • 5.3 Services
    • 5.3.1 Human Tissue Biobanking
    • 5.3.2 Stem Cell Biobanking
    • 5.3.3 Cord Banking
    • 5.3.4 DNA/RNA Biobanking
    • 5.3.5 Other Services
  • 5.4 By Application
    • 5.4.1 Regenerative Medicine
    • 5.4.2 Drug Discovery
    • 5.4.3 Disease Research
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Atlanta Biologicals Inc. (Bio-Techne Corporation)
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 BioLifeSolutions Inc.
    • 6.1.4 Chart Industries Inc.
    • 6.1.5 Hamilton Company
    • 6.1.6 Qiagen NV
    • 6.1.7 Sigma-Aldrich Inc. (Merck KGaA)
    • 6.1.8 STEMCELL Technologies Inc.
    • 6.1.9 Thermo Fisher Scientific Inc.
    • 6.1.10 VWR International LLC
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject To Availablity
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Biobanking Industry Segmentation

Biobanks are the bio-repository, wherein various biomaterials (usually human specimens) are stored for research purposes.

Equipment Cryogenic Storage Systems Refrigerators
Ice Machines
Freezers
Equipment Alarm Monitoring Systems
Other Equipment
Media Optimized Media
Non-optimized Media
Services Human Tissue Biobanking
Stem Cell Biobanking
Cord Banking
DNA/RNA Biobanking
Other Services
By Application Regenerative Medicine
Drug Discovery
Disease Research
Geography North America United States
Canada
Mexico
Need A Different Region Or Segment?
Customize Now

North America Biobanking Market Research FAQs

The North America Biobanks Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)

BioLifeSolutions Inc., Hamilton Company, Sigma-Aldrich Inc. (Merck KGaA), Thermo Fisher Scientific Inc. and VWR International LLC are the major companies operating in the North America Biobanks Market.

The report covers the North America Biobanks Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Biobanks Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

North America Biobank Industry Report

Statistics for the 2024 North America Biobank market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Biobank analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

North America Biobanking Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)